New Target to Treat Psoriasis Identified

Scientists from Sanford-Burnham have discovered T Lymphocyte Attenuator (BTLA) inhibitory receptor as an important factor in limiting inflammatory responses, particularly in the skin. The study, published online today in iImmunity/i, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis. "Our study shows that BTLA expression in gamma-delta T-cells deactivates their response to immune ...